Luise Holzhauser
Overview
Explore the profile of Luise Holzhauser including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holzhauser L, Norris M, Molina M, Chambers S, Sundaravel S, Rashed E, et al.
Clin Transplant
. 2024 Apr;
38(4):e15307.
PMID: 38567897
Background: The use of induction immunosuppression for heart transplantation (HT) is debated given the uncertain benefit and potential risks of infection and malignancy. Methods: This is a retrospective single-center analysis...
2.
Holzhauser L, Reza N, Edwards J, Birati E, Owens A, McLean R, et al.
J Am Heart Assoc
. 2024 Feb;
13(5):e032676.
PMID: 38420765
Background: Annual heart transplant (HT) volumes have increased, as have post-HT outpatient care needs. Data on HT-related emergency department (ED) visits are limited. Methods And Results: A retrospective analysis of...
3.
Defilippis E, Nikolova A, Holzhauser L, Khush K
JACC Heart Fail
. 2023 Aug;
11(9):1181-1188.
PMID: 37589612
Women represent only about 25% of heart transplant recipients annually. Although the number of women living with advanced heart failure remains unknown, epidemiologic research suggests that more women should be...
4.
Holzhauser L, Defilippis E, Nikolova A, Byku M, Contreras J, De Marco T, et al.
JACC Heart Fail
. 2023 Jan;
11(3):263-276.
PMID: 36682960
Noninvasive heart transplant rejection surveillance using gene expression profiling (GEP) to monitor immune activation is widely used among heart transplant programs. With the new development of donor-derived cell-free DNA (dd-cfDNA)...
5.
Moritz A, Holzhauser L, Fuchte T, Kremer S, Schmidt J, Irouschek A
PLoS One
. 2021 Apr;
16(4):e0250369.
PMID: 33886650
Background: Video laryngoscopy is an effective tool in the management of difficult pediatric airway. However, evidence to guide the choice of the most appropriate video laryngoscope (VL) for airway management...
6.
Narang N, Dela Cruz M, Imamura T, Chung B, Nguyen A, Holzhauser L, et al.
Clin Cardiol
. 2021 Mar;
44(5):636-645.
PMID: 33734459
Background: Elevated lactic acid (LA) levels carry a poor prognosis in patients with shock. Data are lacking on the significance of LA levels in patients with acute decompensated heart failure...
7.
Holzhauser L, Clerkin K, Fujino T, Alenghat F, Raikhelkar J, Kim G, et al.
Clin Transplant
. 2020 Dec;
35(3):e14206.
PMID: 33368611
Background: The role of donor-derived cell-free DNA (dd-cfDNA) in screening for cardiac allograft vasculopathy (CAV) is unknown. We hypothesized that dd-cfDNA correlates with CAV, markers of inflammation, and angiogenesis in...
8.
Uriel M, Holzhauser L, Nguyen A, Imamura T, Lourenco L, Rodgers D, et al.
Transplant Proc
. 2020 Dec;
53(2):673-680.
PMID: 33358419
Background: Hyperkalemia (HK) is a life-threatening complication following solid organ transplantation, and patients often need potassium-chelating agents and deviations from standard posttransplant protocols. This is the first study to report...
9.
Fujino T, Kumai Y, Nitta D, Holzhauser L, Nguyen A, Lourenco L, et al.
Clin Transplant
. 2020 Sep;
34(12):e14087.
PMID: 32955148
Hypogammaglobulinemia (HGG) can occur following solid organ transplantation. However, there are limited data describing the prevalence, risk factors, and clinical outcomes associated with HGG following heart transplantation. We retrospectively reviewed...
10.
Holzhauser L, Lourenco L, Sarswat N, Kim G, Chung B, Nguyen A
Am J Transplant
. 2020 May;
20(10):2916-2922.
PMID: 32378314
The coronavirus disease 2019 (COVID-19) pandemic poses special challenges to immunocompromised transplant patients. Given the paucity of proven data in treating COVID-19, management of these patients is difficult, rapidly evolving,...